Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases

Details for Australian Patent Application No. 2004281536 (hide)

Owner IMTM GmbH KeyNeurotek Pharmaceuticals AG

Inventors Ansorge, Siegfried; Nordhoff, Karsten; Tager, Michael; Striggow, Frank; Bank, Ute

Agent Cullen & Co

Pub. Number AU-B-2004281536

PCT Pub. Number WO2005/037257

Priority 103 48 023.4 15.10.03 DE

Filing date 15 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 9 July 2009

International Classifications

C07C 259/06 (2006.01) Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

A61K 31/00 (2006.01)

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

C07C 317/44 (2006.01) Sulfones

C07C 325/02 (2006.01) Thioaldehydes

C07C 327/48 (2006.01) Thiocarboxylic acids

C07D 207/46 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 221/14 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 241/52 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 253/06 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 261/20 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 307/46 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 323/00 (2006.01) Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms

C07D 333/36 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 339/08 (2006.01) Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07F 9/53 Compounds containing elements of the 5th Group of the Periodic System

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/037257 Priority application(s): WO2005/037257

1 June 2006 Change of Name(s) of Applicant(s), Section 104

  KeyNeurotek AG The name of the applicant has been changed to IMTM GmbH; KeyNeurotek AG

13 March 2008 Alteration of Name

  The name of the applicant has been altered to IMTM GmbH; KeyNeurotek Pharmaceuticals AG

9 July 2009 Application Accepted

  Published as AU-B-2004281536

5 November 2009 Standard Patent Sealed

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281541-Tbenazpril and amlodipine for reducing cardiovascular morbidity

2004281535-Connector for medical liquid-containing packages and medical liquid-containing packages